Are Transfusions a Barrier to High-Quality End-of-Life Care in Hematology?
Dr. LeBlanc and Dr. Litzow take a look at an issue within the field consisting of hematologists referring their patients to hospice late or not at all even when there are s
Remission: More Than Meets the Eye
Dr. Teachey reviews a study that suggests that patients in morphologic remission but with high minimal residual disease have inferior outcomes.
The Hematologist offers podcasts that enhance the reading experience by presenting key results and additional insights from published articles in a convenient audio format. All of the podcasts are available for FREE! Learn more
Where to Listen
Listen to the podcasts below (Internet connection required) or download and listen to them later via SoundCloud or iTunes.
In this podcast, Contributing Editor Dr. Omar Abdel-Wahab has a conversation with Drs. Ulrich Steidl and Amit Verma. They discuss Dr. Abdel-Wahab's Diffusion article from the July/August 2018 issue of The Hematologist. The article titled, "New Means to Reactivate p53 in Leukemia: A Staple Peptide Inhibitor of MDMX and MDM2," discusses therapeutic activation of wild-type TP53 in leukemia and other forms of cancer. Read more
In this podcast, Chair of the ASH Committee on Practice Dr. Joseph Alvarnas and Chair of the ASH Committee on Government Affairs Dr. Alan Rosmarin talk about the ASH Congressional Fellowship, a unique opportunity for a hematologist to work in a congressional office on Capitol Hill for an academic year, to help shape health care and hematology policy. We also hear from Dr. Catherine Zander, the first ever ASH Congressional Fellow, as she shares her personal experience with the fellowship. Learn more
In this podcast, Contributing Editor Dr. Caron Jacobson and Dr. Marcela Maus both of Dana Farber Cancer Institute have a thought provoking conversation. They discuss Dr. Jacobson's Diffusion article from the May/June 2018 issue of The Hematologist. The article titled, "In Vivo and In-stantaneous Production of Chimeric Antigen Receptor T Cells: Overcoming Treatment Delays" talks about the in vivo and instantaneous production of chimeric antigen receptor T cells as a way to overcome potentially rate-limiting manufacturing times needed for current ex vivo technologies. Read more
In this podcast, Chair of the ASH Committee on Practice Dr. Joseph Alvarnas has a conversation with Biosimilars Faculty Member Dr. Gary Lyman about the webinar series "Biosimilars: A New Era of Hematology/Oncology Management Considerations." They discuss the significance of these webinars for hematologists and their patients, as well as the importance of preparing clinicians with information that can provide context for the appropriate use of biosimilars. Learn more
In this podcast, Contributing Editor Dr. Michael DeBaun of Vanderbilt University has a conversation with Dr. Joshua Field of BloodCenter of Wisconsin where they cover Dr. DeBaun's Diffusion article from the March/April 2018 issue of The Hematologist. The article titled" What We Know and Do Not Know About Chronic Pain in Adults With Sickle Cell Disease" discusses available information on recurrent chronic pain, the most common problem affecting 50 percent of adults with sickle cell disease (SCD). Read more
July-August 2018Volume 15, Issue 4
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology